Clinical-stage allosterically acting drugs are on track to unlock a stubborn class of targets.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells
Cell Communication and Signaling Open Access 03 April 2024
-
Emerging roles of the Protein Phosphatase 1 (PP1) in the context of viral infections
Cell Communication and Signaling Open Access 24 January 2024
-
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas
Nature Cancer Open Access 17 January 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
PowerPoint slides
Rights and permissions
About this article
Cite this article
Mullard, A. Phosphatases start shedding their stigma of undruggability. Nat Rev Drug Discov 17, 847–849 (2018). https://doi.org/10.1038/nrd.2018.201
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2018.201
This article is cited by
-
Emerging roles of the Protein Phosphatase 1 (PP1) in the context of viral infections
Cell Communication and Signaling (2024)
-
The protein phosphatase-2A subunit PR130 is involved in the formation of cytotoxic protein aggregates in pancreatic ductal adenocarcinoma cells
Cell Communication and Signaling (2024)
-
Inhibition of PPP1R15A alleviates osteoporosis via suppressing RANKL-induced osteoclastogenesis
Acta Pharmacologica Sinica (2024)
-
SHP2 clinical phenotype, cancer, or RASopathies, can be predicted by mutant conformational propensities
Cellular and Molecular Life Sciences (2024)
-
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas
Nature Cancer (2024)